ZA200901478B - Ibuprofen-effervescent preparation having a high dissolution rate and method for the production thereof - Google Patents

Ibuprofen-effervescent preparation having a high dissolution rate and method for the production thereof

Info

Publication number
ZA200901478B
ZA200901478B ZA200901478A ZA200901478A ZA200901478B ZA 200901478 B ZA200901478 B ZA 200901478B ZA 200901478 A ZA200901478 A ZA 200901478A ZA 200901478 A ZA200901478 A ZA 200901478A ZA 200901478 B ZA200901478 B ZA 200901478B
Authority
ZA
South Africa
Prior art keywords
ibuprofen
production
dissolution rate
effervescent
high dissolution
Prior art date
Application number
ZA200901478A
Other languages
English (en)
Inventor
Peter Gruber
Hubert Keck
Original Assignee
Losan Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Losan Pharma Gmbh filed Critical Losan Pharma Gmbh
Publication of ZA200901478B publication Critical patent/ZA200901478B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200901478A 2006-09-26 2009-03-02 Ibuprofen-effervescent preparation having a high dissolution rate and method for the production thereof ZA200901478B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06121278A EP1905428A1 (fr) 2006-09-26 2006-09-26 Comprimé effervescent d'une désintégration rapide et procès pour la preparation

Publications (1)

Publication Number Publication Date
ZA200901478B true ZA200901478B (en) 2010-03-31

Family

ID=37775689

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200901478A ZA200901478B (en) 2006-09-26 2009-03-02 Ibuprofen-effervescent preparation having a high dissolution rate and method for the production thereof

Country Status (22)

Country Link
US (1) US20100172981A1 (fr)
EP (2) EP1905428A1 (fr)
JP (1) JP2010504366A (fr)
KR (1) KR20090074784A (fr)
CN (1) CN101534797B (fr)
AT (1) ATE438387T1 (fr)
AU (1) AU2007302161A1 (fr)
BR (1) BRPI0717084A2 (fr)
CA (1) CA2664420A1 (fr)
CO (1) CO6180421A2 (fr)
DE (1) DE502007001262D1 (fr)
DK (1) DK2061436T3 (fr)
EC (1) ECSP099200A (fr)
ES (1) ES2331438T3 (fr)
IL (1) IL197309A0 (fr)
MX (1) MX2009003065A (fr)
NZ (1) NZ575183A (fr)
PL (1) PL2061436T3 (fr)
PT (1) PT2061436E (fr)
RU (1) RU2478381C2 (fr)
WO (1) WO2008037555A1 (fr)
ZA (1) ZA200901478B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2403033C2 (ru) 2005-03-22 2010-11-10 Лозан Фарма Гмбх Солюбилизированный ибупрофен
KR101683293B1 (ko) * 2009-06-29 2016-12-06 라이온 가부시키가이샤 경구용 조성물
JP5663238B2 (ja) * 2009-08-31 2015-02-04 ライオン株式会社 内服固形製剤及びその製造方法
CN102100686A (zh) * 2009-12-21 2011-06-22 北京润德康医药技术有限公司 一种含有布洛芬与精氨酸的药用组合物及其制备方法、用途
CN102743366B (zh) * 2012-07-16 2013-11-20 海南葫芦娃制药有限公司 对乙酰氨基酚泡腾颗粒及其鉴别方法
RU2706727C2 (ru) 2014-09-17 2019-11-20 Стирлайф Индия Прайвит Лимитед Шипучие композиции и способы их получения и применения
US11219594B2 (en) 2015-12-12 2022-01-11 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
FR3055800B1 (fr) 2016-09-15 2020-06-26 Unither Pharmaceuticals Composition solide a ingestion rapide et deglutition facilitee, sous forme de particules solides non agglomerees, comprenant deux differents types de particules
JP6836375B2 (ja) * 2016-11-21 2021-03-03 花王株式会社 口腔内発泡製剤及びその製造法
GB2595300B (en) * 2020-05-21 2024-03-27 Reckitt Benckiser Health Ltd Novel Formulation
GB2595453B (en) * 2020-05-21 2024-04-03 Reckitt Benckiser Health Ltd Novel Formulation
GB2595301A (en) * 2020-05-21 2021-11-24 Reckitt Benckiser Health Ltd Novel formulation
US20230292992A1 (en) * 2022-03-18 2023-09-21 CapsoVision, Inc. Apparatus for Thermally Stable Capsule Endoscope Using Effervescent Formulation for Controlling Balloon Inflation Rate
WO2023182904A1 (fr) * 2022-03-21 2023-09-28 Акционерное Общество "Производственная Фармацевтическая Компания Обновление" Préparation médicamenteuse en poudre pour la préparation d'une solution, et procédé de production

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
CH677606A5 (fr) * 1988-07-12 1991-06-14 Aesculapius Pharma Sa
DE3838431A1 (de) * 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
CH684929A5 (de) * 1992-11-19 1995-02-15 Sipharm Sisseln Ag Ibuprofen-haltige Brausezusammensetzung und ihre Herstellung.
EP0667149A1 (fr) * 1994-02-14 1995-08-16 E-PHARMA TRENTO S.p.A. Composition effervescente d'ibuprofène
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
DE19606151C2 (de) * 1996-02-20 1999-05-12 Losan Pharma Gmbh Ibuprofen-Brausezubereitung sowie Verfahren zur Herstellung derselben
GB9816899D0 (en) * 1998-08-05 1998-09-30 Boots Co Plc Therapeutic agents
ATE534371T1 (de) * 2003-02-06 2011-12-15 Gebro Pharma Gmbh Pharmazeutische zubereitungen und verfahren zu deren herstellung
WO2006002836A1 (fr) * 2004-07-01 2006-01-12 Losan Pharma Gmbh Compositions effervescentes de somniferes
RU2403033C2 (ru) * 2005-03-22 2010-11-10 Лозан Фарма Гмбх Солюбилизированный ибупрофен
WO2006120281A1 (fr) 2005-05-12 2006-11-16 Perlos Oyj Dispositif de traitement de signaux optiques

Also Published As

Publication number Publication date
US20100172981A1 (en) 2010-07-08
KR20090074784A (ko) 2009-07-07
RU2478381C2 (ru) 2013-04-10
CO6180421A2 (es) 2010-07-19
DE502007001262D1 (de) 2009-09-17
ATE438387T1 (de) 2009-08-15
CA2664420A1 (fr) 2008-04-03
ECSP099200A (es) 2009-06-30
CN101534797A (zh) 2009-09-16
CN101534797B (zh) 2012-03-28
EP2061436A1 (fr) 2009-05-27
ES2331438T3 (es) 2010-01-04
NZ575183A (en) 2012-03-30
AU2007302161A1 (en) 2008-04-03
JP2010504366A (ja) 2010-02-12
WO2008037555A1 (fr) 2008-04-03
PT2061436E (pt) 2009-10-30
BRPI0717084A2 (pt) 2013-10-29
IL197309A0 (en) 2009-12-24
RU2009107536A (ru) 2010-11-20
PL2061436T3 (pl) 2009-12-31
DK2061436T3 (da) 2009-11-02
EP1905428A1 (fr) 2008-04-02
MX2009003065A (es) 2009-05-28
EP2061436B1 (fr) 2009-08-05

Similar Documents

Publication Publication Date Title
ZA200901478B (en) Ibuprofen-effervescent preparation having a high dissolution rate and method for the production thereof
WO2008105521A1 (fr) Agent floculant magnétique, son procédé de fabrication et procédé de purification de l'eau à l'aide de l'agent floculant magnétique
EA200702552A1 (ru) Непрерывный способ получения хлоргидринов
MY147871A (en) Chemical process for preparation of aromatic cyclopropane esters and amides
WO2007005633A8 (fr) Procede de preparation d'une forme posologique liquide contenant du 4-phenylbutyrate de sodium
MX2009013255A (es) Matriz de solidificacion que incluye una sal de un acido mono-, di- o tri-carboxilico saturado de cadena recta.
SG149080A1 (en) Composition comprising a nsaid and paracetamol
WO2007056041A3 (fr) Procede de production d'une solution saline de nickel
MY157074A (en) Conversion method
WO2012075091A3 (fr) Acide de synthèse et procédés associés
HK1108153A1 (en) Ionized water and method of producing same
WO2008021463A3 (fr) Analogues de diaryl[a,d]cycloheptène à substitution amino, utilisés comme agonistes muscariniques et méthodes de traitement de troubles neuropsychiatriques
JP2010514664A5 (fr)
HK1084938A1 (en) Method for the production of levosalbutamol or (r)-salbutamol
DE602007007986D1 (de) Galenische form zur transmukosalen verabreichung von paracetamol
WO2003097526A3 (fr) Procede relatif a l'elaboration et a l'utilisation d'une formulation de chlorite de sodium stable
TW200509814A (en) Platinum nanocolloid solution and its production method, and drinks containing platinum nanocolloid
CY1112047T1 (el) Διαδικασια για την παρασκευη γκαμπαπεντινης
SI2094116T1 (sl) Trdni ali vodni alkalni pripravek ki obsega kreatinsko komponento postopek za njegovo pripravo innjegova uporaba
HK1119658A1 (en) Method for producing acetoacetic acid arylamides
NZ611208A (en) Effervescent composition for improved carbon dioxide generation in insect monitor devices
AR056469A1 (es) Ibuprofeno solubilizado
WO2008155920A1 (fr) Médicament ayant pour effet de favoriser la croissance des hépatocytes
WO2004093827A3 (fr) Sels d'acide phenolique de gabapentine en formes posologiques solides et procedes d'utilisation
FR2956810B1 (fr) Composition cosmetique a base d'acide ellagique ou d'un de ses derives et d'un melange particulier de tensioactifs anioniques et amphoteres ou zwitterioniques.